On your point about CHF, I’ll take you back to 2015.
https://www.asx.com.au/asxpdf/20150930/pdf/431pvh6kpvwr6l.pdf
Now tell me - how is it that they can say, in 2015, after a post-hoc analysis, that their agent works best in the sickest patients and now they are saying it works in the least sick CHF patients?
If that doesn’t raise flags, I don’t know what else could.
USD573M in retained losses and a less than great 2020!. 2021 a year that cannot get worse, page-7
-
- There are more pages in this discussion • 305 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.17 |
Change
-0.025(2.10%) |
Mkt cap ! $1.330B | |||
| Open | High | Low | Value | Volume |
| $1.18 | $1.22 | $1.15 | $6.344M | 5.404M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8683 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.17 | 32999 | 1 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |